ngµç×ÓÓÎÏ·

05

¿ÆÑÐÏ£Íû

Á¥ÊôµÚÁùÒ½ÔºÀîÃϺèÍŶӽÒÃØCSN6ÔõÑùµ÷¿Ø·ÊÅÖÈËȺ¸Îϸ°û°©Ï£Íû

¸å¼þȪԴ£º£ºÁ¥ÊôµÚÁùÒ½Ôº ±à¼­£º£ºÂ¬ì½Î¬ ÉóºË£º£ºËïÒ«±ó ÔĶÁÁ¿£º£º

ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±ÕÅæÃæÃ¡¢¡¢´÷Ï£°²¡¢¡¢¼òÎÄÑ¿ËÈÕ£¬£¬Á¥ÊôµÚÁùҽԺ賦²¡Ñ§Ñо¿ËùÀîÃϺè½ÌÊÚ¼°ÆäÏàÖúÍŶÓÔÚAdvanced Science£¨2022IF=15.1£©ÔÓÖ¾ÉϽÒÏþÁËÌâΪ ¡°CSN6-SPOP-HMGCS1 Axis Promotes Hepatocellular Carcinoma Progression via YAP1 Activation¡± µÄÑо¿ÂÛÎÄ¡£¡£¸ÃÑо¿·¢Ã÷COP9ÐźÅСÌåÑÇ»ù6 (CSN6) ͨ¹ýÞ׿¹ºÚµãÐÍPOZÂÑ°× (SPOP) ·ºËØÅþÁ¬Ã¸ÎȹÌHMGCS1£¬£¬½ø¶ø¼¤»îYAP1Ôö½øÖ×ÁöµÄÉú³¤£¬£¬Îª°ÐÏòÖ×Áö´úлÒì³£µÄ¾«×¼ÖÎÁÆÌṩÁËÐÂ˼Ð÷¡£¡£

ÏÖÔÚ£¬£¬¸Î°©ÊÇÒ»¸öÈ«ÇòÐԵĿµ½¡ÎÊÌ⣬£¬Æä·¢²¡ÂʺÍéæÃüÂÊÔÚÌìϹæÄ£ÄÚÒ»Ö±ÉÏÉý£¬£¬ÆäÖУ¬£¬¸Îϸ°û°© (Hepatocellular carcinoma, HCC) ÊÇ×î³£¼ûµÄ¸Î°©ÐÎʽ£¬£¬Ô¼ÄªÕ¼¸Î°©×ܲ¡ÀýÊýµÄ90%¡£¡£Áè¼Ý90%µÄHCC²¡Àý±¬·¢ÔÚÓÐÂýÐԸβ¡µÄÅä¾°Ï£¬£¬ÈκÎÔì³É¸ÎÓ²»¯µÄ²¡Òò¶¼ÊÇHCCµÄΣÏÕÒòËØ£¬£¬Ö÷Òª°üÀ¨ÒҸλò±û¸Î²¡¶¾Ñ¬È¾¡¢¡¢ÂýÐÔÒû¾Æ¡¢¡¢ÌÇÄò²¡»ò·ÊÅÖÏà¹ØµÄ·Ç¾Æ¾«ÐÔÖ¬·¾¸Î²¡(Non-alcoholic fatty liver diseases, NAFLD) µÈ¡£¡£Ëæ×Å·ÊÅÖµÄÊ¢ÐУ¬£¬NAFLDÔ¤¼Æ½«³ÉΪδÀ´HCCµÄÖ÷ÒªÔ­Òò£¬£¬¶øµ¨¹Ì´¼Éý¸ßÊÇNAFLDÏà¹Ø°©Ö¢µÄÖ÷ÒªÖ¸±êÖ®Ò»£¬£¬µ¨¹Ì´¼ÓÉÒÒõ£¸¨Ã¸A¾­ÓÉ30²½Ã¸´Ù·´Ó³ºÏ³É£¬£¬¼´¼×ôÇÎìËá (MVA) ºÏ³É;¾¶¡£¡£Ñо¿°ÐÏòµ¨¹Ì´¼ºÏ³É;¾¶£¬£¬ÓÐÀûÓÚ·¢Ã÷Ô½·¢Çå¾²ÓÐÓõÄNAFLDÏà¹ØHCCµÄÖÎÁÆ·½°¸ÓëÕ½ÂÔ¡£¡£

Ñо¿ÍŶӽÓÄÉ´óÊý¾Ý¾ÙÐÐÁªºÏ¸Î°©×é֯΢ÕóÁÐÃâÒß×黯ÆÊÎö£¬£¬·¢Ã÷CSN6ÔÚÖ×Áö×éÖ¯Öбí´ïÉϵ÷ÇÒÓ벡ÈËÉúÑÄÂʵÍÏÔÖøÏà¹Ø¡£¡£½øÒ»²½£¬£¬½ÓÄÉCRISPR-Cas9»ùÒò±à¼­ÏµÍ³¹¹½¨¸ÎÔàÌØÒìÐÔCSN6»ùÒòÇóýСÊ󣬣¬Í¨¹ý¹¹½¨Ô­Î»¸Î°©×Ô¾õÄ£×Ó£¬£¬Ñо¿ÍŶӷ¢Ã÷¸ÎÔàÌØÒìÐÔÇóýCSN6¿ÉÒÖÖÆ¸ÎÔàÖ×ÁöÉú³¤£¬£¬²¢½µµÍСÊóѪҺµ¨¹Ì´¼Ë®Æ½£¬£¬ÕâÌáÐÑCSN6Ôڸΰ©±¬·¢¿ªÕ¹ÖÐʩչÖ÷Òª×÷Óᣡ£

ΪÁËÆÊÎöCSN6Ôڸΰ©ÖеÄ×÷ÓûúÖÆ£¬£¬Ñо¿ÍŶÓͨ¹ýÃâÒß¹²³ÁµíÖÊÆ×ºÍ¶¨Á¿ÂѰ×ÖÊ×éѧÆÊÎö£¬£¬È·¶¨ÁË68¸öDZÔÚµÄCSN6Ö±½Ó×÷Óðе㣬£¬²¢·¢Ã÷CSN6Ö±½ÓÁ¬Ïµ²¢µ÷¿ØHMGCS1£¨MVAºÏ³ÉÏà¹ØÍ¾¾¶Òªº¦Ã¸£¬£¬´ß»¯ÒÒõ£ÒÒõ£¸¨Ã¸A£¬£¬ÌìÉú¦Â-ôÇ»ù-¦Â-¼×»ùÎì¶þõ£¸¨Ã¸A£¨HMG-CoA£©£©µÄÂѰ×ÖÊˮƽ¡£¡£½øÒ»²½£¬£¬·¢Ã÷CSN6¿ÉÒÔµ÷ÀíMDM2µÄÎȹÌÐÔ£¬£¬´Ó¶øÆÆËðE3ÅþÁ¬Ã¸SPOPµÄÎȹÌÐÔ£¬£¬·´¿¹SPOP½éµ¼µÄHMGCS1µÄ·ºËØ»¯ºÍ½µ½âÀú³Ì¡£¡£Òò´Ë£¬£¬CSN6µ÷¿ØHMGCS1ÂѰ׵ÄÎȹÌÐÔ£¬£¬½ø¶øÔö½øMVA;¾¶ºÍYAP1µÄת¼¼¤»î£¬£¬´Ó¶øÔö½øÖ×ÁöµÄ¶ñÐÔÏ£Íû¡£¡£±¾Ñо¿µÚÒ»´ÎÅжÏÁ½¸ö×ÅÃûE3ÅþÁ¬Ã¸MDM2ºÍSPOPÖ®¼ä±£´æÏ໥µ÷¿Ø£¬£¬·¢Ã÷MDM2Ϊ×ÅÃûÒÖ°©»ùÒòSPOPµÄE3ÅþÁ¬Ã¸£¬£¬ÌáÐÑSPOP³ýÁËÔÚÖ×ÁöÍ»±äÖ®Í⣬£¬ÆäµÍ±í´ïÒ²ÊÇÓÕ·¢Ö×ÁöµÄÖ÷ÒªÒòËØÖ®Ò»¡£¡£

95746A9011B5BA604EB1DC5C478_DC1B47E0_124150

×îºó£¬£¬Ñо¿ÍŶӹ¹½¨ÁË»¼ÕßȪԴµÄÖ×ÁöÒìÖÖÒÆÖ²Ä£×Ó£¬£¬·¢Ã÷ÔÚCSN6¸ß±í´ïµÄÖ×ÁöÖУ¬£¬ °ÐÏòÒÖÖÆHMGCS1Ìá¸ßÁËYAP1ÒÖÖÆ¼ÁµÄÁÆÐ§¡£¡£¸ÃÑо¿È·¶¨ÁËCSN6-HMGCS1-YAP1ÖáÔڽ鵼HCC±¬·¢¿ªÕ¹ÖеÄÒªº¦×÷Óᣡ£

×ÛÉÏ£¬£¬¸ÃÑо¿Í¨¹ýÁÙ´²×é֯оƬ£¬£¬»ùÒòÇóýСÊóºÍÂѰ×ÖÊ×éѧµÈÊֶΣ¬£¬ÅжÏÁË·ÊÅÖÒÔ¼°NAFLDÏà¹Ø¸Î°©±¬·¢¿ªÕ¹µÄ·Ö×Ó»úÖÆ£¬£¬Ú¹ÊÍÁËÖ¬´úлÒì³£Óë¸Î°©Ï£ÍûµÄDZÔÚÔ­Òò£¬£¬ÎªNAFLDÏà¹ØHCC»¼ÕßµÄÁÙ´²ÖÎÁÆÌṩÁËDZÔÚµÄÖ¸µ¼Õ½ÂÔÓëÒªÁì¡£¡£

6696CBF4DF86FE2205FF5EA2430_1D30D376_526A6

±¾ÂÛÎÄͨѶ×÷ÕßΪngµç×ÓÓÎÏ·Á¥ÊôµÚÁùÒ½Ôº½ÌÊÚÀîÃϺè¡¢¡¢ôßÄÏ´óѧҽѧԺ½ÌÊÚÕź£ÅôºÍngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐĽÌÊÚÖÜÖÙ¹ú£¬£¬µÚÒ»×÷ÕßΪngµç×ÓÓÎÏ·Á¥ÊôµÚÁùÒ½Ôº¸±Ñо¿Ô±Àî¿­¡¢¡¢²©Ê¿ºóÕÅ¼ÒØ¹¡¢¡¢²©Ê¿Ñо¿ÉúÂÀº£ÎĺÍ˶ʿÑо¿ÉúÑî½ðÄÜ¡£¡£±¾Ñо¿»ñµÃÁ˹ú¼ÒÖØµãÑз¢ÍýÏëºÍ¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðµÈÏîÄ¿×ÊÖú¡£¡£

ÂÛÎÄÁ´½Ó£º£ºhttps://doi.org/10.1002/advs.202306827


¡¾ÍøÕ¾µØÍ¼¡¿